Skip to main content

Table 1 Patient demographics and clinical characteristics

From: Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism

Demographic

Cinacalcet withdrawal patients (n = 51)

Control patients (n = 51)

p value

Age, years

69.6 (13.2)

68.6 (12.9)

ns

Gender (male)

28 (55)

28 (55)

ns

Dialysis modality (HD)

44 (86)

29 (57)

p = 0.001

Time on dialysis, years

7.1 (3.6)

6.7 (4.1)

ns

Diabetes

23 (45)

23(45)

ns

Hypertension

39 (76)

33 (65)

ns

Ischemic heart disease

23 (45)

18 (35)

ns

Peripheral vascular disease

8 (15)

15 (29)

ns

Current or ex-smoker

16 (31)

17 (33)

ns

Previous transplants

4 (8)

2 (4)

ns

Parathyroidectomy

1 (2)

5 (10)

ns

Previous fractures

7 (13)

4 (8)

ns

Aetiology of renal disease

Diabetic nephropathy

14 (27)

18 (35)

ns

GN

9 (17)

12 (23)

ns

PKD

3 (6)

4 (8)

ns

Other

25

17

ns

Events during follow up

Cardiac arrest

5

3

ns

Parathyroidectomy and referral for surgery

5

1

ns

Fracture

2

5

ns

Calciphylaxis

1

0

ns

Deaths

13

10

ns

Hypercalcemia at baseline

3

1

ns

Hypercalcemia at 6 months

9

0

p = 0.007

Hypercalcemia at 12 months

3

0

ns

  1. Data presented as number (percent), or mean (standard deviation)
  2. Hypercalcemia if Ca > 2.6 mmol/L
  3. Abbreviations: HD hemodialysis, GN glomerulonephritis, PKD polycystic kidney disease